ALX ONCOLOGY HOLDINGS INC Finance Lease, Liability, Payments, Due in Next Rolling Twelve Months
ALX ONCOLOGY HOLDINGS INC (ALXO) had Finance Lease, Liability, Payments, Due in Next Rolling Twelve Months of $616.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Leases › Finance Lease, Liability, to be Paid, Rolling Maturity
us-gaap:FinanceLeaseLiabilityPaymentsDueInNextRollingTwelveMonths · last filed 2026-08-06
- 2026-06-30: Finance Lease, Liability, Payments, Due in Next Rolling Twelve Months $616.00K.
- 2026-03-31: Finance Lease, Liability, Payments, Due in Next Rolling Twelve Months $616.00K.
- 2025-12-31: Finance Lease, Liability, Payments, Due in Next Rolling Twelve Months $1.06M.
- 2025-09-30: Finance Lease, Liability, Payments, Due in Next Rolling Twelve Months $1.06M.
| Period end | Finance Lease, Liability, Payments, Due in Next Rolling Twelve Months |
|---|---|
| 2026-06-30 | $616.00K 10-Q · filed 2026-08-06 |
| 2026-03-31 | $616.00K 10-Q · filed 2026-05-08 |
| 2025-12-31 | $1.06M 10-K · filed 2026-03-09 |
| 2025-09-30 | $1.06M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $1.15M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $1.15M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $1.06M 10-K · filed 2025-03-06 |
| 2024-09-30 | $1.06M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $1.06M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $1.06M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $1.06M 10-K · filed 2024-03-07 |
| 2022-12-31 | $288.00K 10-K · filed 2023-03-09 |
| 2022-09-30 | $288.00K 10-Q · filed 2022-11-08 |
| 2022-06-30 | $288.00K 10-Q · filed 2022-08-08 |
| 2022-03-31 | $288.00K 10-Q · filed 2022-05-09 |
| 2021-12-31 | $432.00K 10-K · filed 2022-02-28 |
| 2021-09-30 | $432.00K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $432.00K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $96.00K 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |